These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16719378)

  • 1. Determination of CYP2B6 component of 7-ethoxy-4-trifluoromethylcoumarin O-deethylation activity in human liver microsomes.
    Chang TK; Crespi CL; Waxman DJ
    Methods Mol Biol; 2006; 320():97-102. PubMed ID: 16719378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the CYP2B6 component of 7-ethoxy-4-trifluoromethylcoumarin O-deethylation activity in human liver microsomes.
    Chang TK; Crespi CL; Waxman DJ
    Methods Mol Biol; 1998; 107():117-22. PubMed ID: 14577219
    [No Abstract]   [Full Text] [Related]  

  • 3. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.
    Code EL; Crespi CL; Penman BW; Gonzalez FJ; Chang TK; Waxman DJ
    Drug Metab Dispos; 1997 Aug; 25(8):985-93. PubMed ID: 9280407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of purported probes of human CYP2B6.
    Ekins S; VandenBranden M; Ring BJ; Wrighton SA
    Pharmacogenetics; 1997 Jun; 7(3):165-79. PubMed ID: 9241656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic method for measurement of cytochrome P450-mediated metabolism of 7-ethoxy-4-trifluoromethylcoumarin.
    Morse MA; Lu J
    J Chromatogr B Biomed Sci Appl; 1998 Apr; 708(1-2):290-3. PubMed ID: 9653975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
    Lau AJ; Chang TK
    Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes.
    Renwick AB; Lavignette G; Worboy PD; Williams B; Surry D; Lewis DF; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2001 Dec; 31(12):861-78. PubMed ID: 11780761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles.
    Roy P; Yu LJ; Crespi CL; Waxman DJ
    Drug Metab Dispos; 1999 Jun; 27(6):655-66. PubMed ID: 10348794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes.
    Yamazaki H; Inoue K; Mimura M; Oda Y; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Feb; 51(3):313-9. PubMed ID: 8573198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of human CYP2B6 in S-mephobarbital N-demethylation.
    Kobayashi K; Abe S; Nakajima M; Shimada N; Tani M; Chiba K; Yamamoto T
    Drug Metab Dispos; 1999 Dec; 27(12):1429-33. PubMed ID: 10570024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling.
    Spatzenegger M; Liu H; Wang Q; Debarber A; Koop DR; Halpert JR
    J Pharmacol Exp Ther; 2003 Jan; 304(1):477-87. PubMed ID: 12490624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of cytochrome P450 2B6 allelic variants.
    Jinno H; Tanaka-Kagawa T; Ohno A; Makino Y; Matsushima E; Hanioka N; Ando M
    Drug Metab Dispos; 2003 Apr; 31(4):398-403. PubMed ID: 12642465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
    Yanagihara Y; Kariya S; Ohtani M; Uchino K; Aoyama T; Yamamura Y; Iga T
    Drug Metab Dispos; 2001 Jun; 29(6):887-90. PubMed ID: 11353758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.
    Turpeinen M; Nieminen R; Juntunen T; Taavitsainen P; Raunio H; Pelkonen O
    Drug Metab Dispos; 2004 Jun; 32(6):626-31. PubMed ID: 15155554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of in vitro cytochrome P450 2B6 activity.
    Walsky RL; Obach RS
    Curr Protoc Toxicol; 2009; Chapter 4():Unit4.27. PubMed ID: 23045012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation of mifepristone [RU486; 17beta-hydroxy-11beta-(4-dimethylaminophenyl)-17alpha-(1-propynyl)-estra-4,9-dien-3-one] by mammalian cytochromes P450 and the mechanism-based inactivation of human CYP2B6.
    Lin HL; Zhang H; Hollenberg PF
    J Pharmacol Exp Ther; 2009 Apr; 329(1):26-37. PubMed ID: 19168709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation.
    Xie HJ; Yasar U; Lundgren S; Griskevicius L; Terelius Y; Hassan M; Rane A
    Pharmacogenomics J; 2003; 3(1):53-61. PubMed ID: 12629583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes.
    Bae SK; Cao S; Seo KA; Kim H; Kim MJ; Shon JH; Liu KH; Zhou HH; Shin JG
    Drug Metab Dispos; 2008 Aug; 36(8):1679-88. PubMed ID: 18474675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative metabolism of BDE-99 by human liver microsomes: predominant role of CYP2B6.
    Erratico CA; Szeitz A; Bandiera SM
    Toxicol Sci; 2012 Oct; 129(2):280-92. PubMed ID: 22738989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
    Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.